Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins.

Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

1976 • 721 citations

Activation of the alternate pathway of human complements by rabbit cells.

1974 • 473 citations

A new complement function: solubilization of antigen-antibody aggregates.

1975 • 303 citations

Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.

1975 • 267 citations

Metabolic Studies of the Third Component of Complement and the Glycine-Rich Beta Glycoprotein in Patients with Hypocomplementemia

1974 • 156 citations

The alternate pathway of complement activation. The role of C3 and its inactivator (KAF).

1973 • 153 citations

Variable patterns of immunoglobulin and complement deposition in the kidneys of patients with systemic lupus erythematosus.

1969 • 136 citations

Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation

1976 • 134 citations

Metabolism of Third Complement Component (C3) in Nephritis

1972 • 130 citations

Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathway.

1976 • 109 citations

Properdin and C3 Proactivator: Alternate Pathway Components in Human Glomerulonephritis

1973 • 95 citations

Kinetic Assessment of Alternative Complement Pathway Activity in a Hemolytic System. I. Experimental and Mathematical Analyses

1978 • 83 citations

Studies of serum complement in the hypocomplementaemic nephritides.

1974 • 78 citations

Decreased Properdin Activity in Acute Glomerulonephritis

1969 • 51 citations

The Modulation of the Alternative Pathway of Complement in C2-Deficient Human Serum by Changes in Concentration of the Component and Control Proteins

1978 • 47 citations

Quantitation of C3PA (properdin factor B) and other complement components in diseases associated with a low C3 level

1973 • 47 citations

Requirements for beta1H globulin and C3b inactivator in the control of the alternative complement pathway in human serum.

1978 • 33 citations

C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.

1976 • 31 citations

A Simple Automated Method for Complement Estimation in a Continuous Flow System

1972 • 29 citations

Metabolism of properdin in normal subjects and patients with renal disease.

1975 • 27 citations

Properdin levels in systemic lupus erythematosus and membranoproleferative glomerulonephritis.

1974 • 25 citations

Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.

1977 • 24 citations

Studies of the C3 Shunt Activation in Cobra Venom Induced Lysis of Unsensitized Erythrocytes

1972 • 23 citations

Metabolism of human beta 1H: studies in man and experimental animals.

1979 • 21 citations

Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.

1979 • 19 citations

Relationships between the haemolytic activities of the human complement system and complement components.

1979 • 16 citations

A Hemolytic Plate Method for Alternative-pathway Complement Activity Assay

1978 • 13 citations

The quantitation of alternative pathway complement function by timed lysis assay

1979 • 5 citations